MSD discontinues two Keytruda trials

MSD has stopped two late-stage trials that tested its blockbuster immunotherapy Keytruda as a treatment for skin and lung cancer.

Samuel Lagercrantz: ”Är det de sämsta biotechbolagen som går under? Eller finns andra faktorer?”

Icellate Medical, Calmark Sweden, Redwood Pharma, Medfield Diagnostics, Coala Life, Cline Scientific och Ectin Research. Listan med life science-företag som gåt...

SupraCube - In life Science

Superconductors must be permanently kept below their transition temperature for levitation. Because of the integrated cooler, applications with superconductors ...

Scale Up Your Image Analysis

ZEISS arivis Hub for accelerated analysis and faster results.

Accelerate your Research with AI-Powered Image Analysis

Comprehensive eBook from ZEISS.

Bioscience – Groundbreaking Research & Diagnostics: Stockholm

Takeover bid is being completed – Japanese company acquires Calliditas

Japanese company Asahi Kasei completes the bid for Calliditas Therapeutics after reaching over 90 percent of the shareholding. Callidita's board has now decided...

Quality Assurance for the Highest Medical Standards

Metrology Solutions for Medical Components.

Anna Törner: Yes, I Am Sick, But Not Weak

”People often say that someone who is ill only has one wish—to get better. But I think that is not true. Someone who is ill also longs to be understood, to be r...

Norwegian cancer research companies merge

The Norwegian companies Ultimovacs and Zelluna Immunotherapy plan to merge. At the same time, it is made clear that Ultimovacs' CEO is leaving the company.

Efter Trumps nedskärningar – nu ska EU locka över amerikanska toppforskare

USA drar in på statliga forskningsanslag – då ser europeiska aktörer sin chans att locka till sig forskarbegåvningar från andra sidan Atlanten.

Svensk läkemedelsdoldis ny på lista över dollarmiljardärer

Doldisen Per Sandberg, storägare i läkemedelsbolaget Camurus, hör till en av världens mest förmögna personer. Bland de namn som hängt med från tidigare års list...

Ännu ett Alzheimerläkemedel godkänt – lecanemab får konkurrens

Eli Lillys läkemedel donanemab mot Alzheimers godkändes på tisdagen av den amerikanska läkemedelsmyndigheten FDA. Det är det andra godkända bromsläkemedlet mot ...

Ingrid Lönnstedt: ”The confidence interval and its width”

Always keep an eye on the width of your and others’ confidence intervals, writes Ingrid Lönnstedt in a science column.

Join the premier metrology and quality assurance event of the year

ZEISS QUALITY INNOVATION SUMMIT in Berlin, October 22-24, 2024.

Trump i nytt försök att pressa läkemedelspriser

USA:s president Donald Trump meddelade på söndagen att han tänker underteckna en presidentorder för att sänka priserna på receptbelagda läkemedel till samma niv...

Japanese pharma to buy US drugmaker for $2.4 bln

Japanese Ono Pharmaceutical buys the American cancer drug developer Deciphera Pharmaceuticals in one of the largest acquisitions in the industry so far this year.

About Microscope Ergonomics

Learn about ergonomic microscope design and how you can increase your well-being and productivity when working in clinical microscopy. Read about challenges, de...

Controlled Pneumatics: pushing the boundaries of pneumatics

Pressure, flow rate and movement can now be controlled very precisely, and with exactly the energy actually required. Controlled Pneumatics is the combination o...

Leo Pharma to cut 200 jobs and reorganize

Danish Leo Pharma cuts down on staff in its global operations. Around 200 positions will be cut, while 50 will be moved to Poland.

This years Nobel prize in medicine – “Changed the understanding of how genes are controlled”

This year’s Nobel Prize in Physiology or Medicine goes to the discovery that small RNA molecules, known as microRNAs, control how genes are regulated. Understan...

Den enes snor blir den andres bot

Snortransplantation – ordet ger rysningar. Nu presenteras en studie där skånska patienter med kronisk tjock snuva, förbättrades efter att ha använt nässprej inn...

Healthcare study: Alzheimer’s blood test shows high accuracy

A blood test for identifying Alzheimer’s has now been tested in the general healthcare setting. According to the researchers, the test was 90% accurate in making a diagnosis.

The investor: “The major common diseases are hot again”

She has previously been voted Investor of the Year and will now be moderating The Future of Swedish & Danish Life Science congress. We check the temperature of ...